Amgen Shares Fall as Investors Assess Novartis Lp(a) Trial Result and BMO Downgrade
Amgen (NASDAQ:AMGN) shares fell 4. 7% to $416.
Search
Search covers the most recently published. For the full archive, browsethe topics.
1 result for"Novartis"
Tuesday, September 8, 2026
Search covers the most recently published. For the full archive, browsethe topics.
1 result for"Novartis"
Amgen (NASDAQ:AMGN) shares fell 4. 7% to $416.